<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33974561</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2379-3708</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>11</Issue><PubDate><Year>2021</Year><Month>Jun</Month><Day>08</Day></PubDate></JournalIssue><Title>JCI insight</Title><ISOAbbreviation>JCI Insight</ISOAbbreviation></Journal><ArticleTitle>NK cells associate with ALS in a sex- and age-dependent manner.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e147129</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1172/jci.insight.147129</ELocationID><ELocationID EIdType="pii" ValidYN="Y">147129</ELocationID><Abstract><AbstractText>NK cells are innate immune cells implicated in ALS; whether NK cells impact ALS in a sex- and age-specific manner was investigated. Herein, NK cells were depleted in male and female SOD1G93A ALS mice, survival and neuroinflammation were assessed, and data were stratified by sex. NK cell depletion extended survival in female but not male ALS mice with sex-specific effects on spinal cord microglia. In humans, NK cell numbers, NK cell subpopulations, and NK cell surface markers were examined in prospectively blood collected from subjects with ALS and control subjects; longitudinal changes in these metrics were correlated to revised ALS functional rating scale (ALSFRS-R) slope and stratified by sex and age. Expression of NK cell trafficking and cytotoxicity markers was elevated in subjects with ALS, and changes in CXCR3+ NK cells and 7 trafficking and cytotoxicity markers (CD11a, CD11b, CD38, CX3CR1, NKG2D, NKp30, NKp46) correlated with disease progression. Age affected the associations between ALSFRS-R and markers NKG2D and NKp46, whereas sex impacted the NKp30 association. Collectively, these findings suggest that NK cells contribute to ALS progression in a sex- and age-specific manner and demonstrate that age and sex are critical variables when designing and assessing ALS immunotherapy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Murdock</LastName><ForeName>Benjamin J</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>Department of Neurology and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Famie</LastName><ForeName>Joshua P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Department of Neurology and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piecuch</LastName><ForeName>Caroline E</ForeName><Initials>CE</Initials><AffiliationInfo><Affiliation>Department of Neurology and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pawlowski</LastName><ForeName>Kristen D</ForeName><Initials>KD</Initials><AffiliationInfo><Affiliation>Department of Neurology and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mendelson</LastName><ForeName>Faye E</ForeName><Initials>FE</Initials><AffiliationInfo><Affiliation>Department of Neurology and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pieroni</LastName><ForeName>Cole H</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Department of Neurology and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iniguez</LastName><ForeName>Sebastian D</ForeName><Initials>SD</Initials><AffiliationInfo><Affiliation>Department of Neurology and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Lili</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goutman</LastName><ForeName>Stephen A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Department of Neurology and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feldman</LastName><ForeName>Eva L</ForeName><Initials>EL</Initials><AffiliationInfo><Affiliation>Department of Neurology and.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 TS000289</GrantID><Acronym>TS</Acronym><Agency>ATSDR CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01TS000289</GrantID><Acronym>ACL</Acronym><Agency>ACL HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 NS092091</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 ES027221</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 ES030049</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 NS102960</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JCI Insight</MedlineTA><NlmUniqueID>101676073</NlmUniqueID><ISSNLinking>2379-3708</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000950">Antigens, Ly</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C527211">Klrb1c protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D055651">NK Cell Lectin-Like Receptor Subfamily B</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="C109415">SOD1 G93A protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000950" MajorTopicYN="N">Antigens, Ly</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015496" MajorTopicYN="N">CD4-Positive T-Lymphocytes</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018414" MajorTopicYN="N">CD8-Positive T-Lymphocytes</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004804" MajorTopicYN="N">Eosinophils</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007694" MajorTopicYN="N">Killer Cells, Natural</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007962" MajorTopicYN="N">Leukocytes</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009000" MajorTopicYN="N">Monocytes</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055651" MajorTopicYN="N">NK Cell Lectin-Like Receptor Subfamily B</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000090862" MajorTopicYN="N">Neuroinflammatory Diseases</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009504" MajorTopicYN="N">Neutrophils</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">Immunology</Keyword><Keyword MajorTopicYN="N">NK cells</Keyword><Keyword MajorTopicYN="N">Neuroscience</Keyword></KeywordList><CoiStatement><b>Conflict of interest:</b> BJM, SAG, and ELF are listed as inventors on a patent held by University of Michigan (issue no. US10660895, &#x201c;Methods for Treating Amyotrophic Lateral Sclerosis&#x201d;) that targets immune pathways for use in ALS therapeutics.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>12</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>5</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>11</Day><Hour>17</Hour><Minute>20</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33974561</ArticleId><ArticleId IdType="pmc">PMC8262328</ArticleId><ArticleId IdType="doi">10.1172/jci.insight.147129</ArticleId><ArticleId IdType="pii">147129</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Goutman SA. Diagnosis and clinical management of amyotrophic lateral sclerosis and other motor neuron disorders. Continuum (Minneap Minn) 2017;23(5, Peripheral Nerve and Motor Neuron Disorders):1332&#x2013;1359.</Citation><ArticleIdList><ArticleId IdType="pubmed">28968365</ArticleId></ArticleIdList></Reference><Reference><Citation>Murdock BJ, et al. The dual roles of immunity in ALS: injury overrides protection. Neurobiol Dis. 2015;77:1&#x2013;12. doi: 10.1016/j.nbd.2015.02.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2015.02.017</ArticleId><ArticleId IdType="pubmed">25726748</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W, et al. Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis. J Neuroimmune Pharmacol. 2013;8(4):888&#x2013;899. doi: 10.1007/s11481-013-9489-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-013-9489-x</ArticleId><ArticleId IdType="pmc">PMC4126425</ArticleId><ArticleId IdType="pubmed">23881705</ArticleId></ArticleIdList></Reference><Reference><Citation>Murdock BJ, et al. Correlation of peripheral immunity with rapid amyotrophic lateral sclerosis progression. JAMA Neurol. 2017;74(12):1446&#x2013;1454. doi: 10.1001/jamaneurol.2017.2255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2017.2255</ArticleId><ArticleId IdType="pmc">PMC5822195</ArticleId><ArticleId IdType="pubmed">28973548</ArticleId></ArticleIdList></Reference><Reference><Citation>Butovsky O, et al. Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS. J Clin Invest. 2012;122(9):3063&#x2013;3087. doi: 10.1172/JCI62636.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI62636</ArticleId><ArticleId IdType="pmc">PMC3428086</ArticleId><ArticleId IdType="pubmed">22863620</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JD, et al. Complement components are upregulated and correlate with disease progression in the TDP-43Q331K mouse model of amyotrophic lateral sclerosis. J Neuroinflammation. 2018;15(1):171. doi: 10.1186/s12974-018-1217-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-018-1217-2</ArticleId><ArticleId IdType="pmc">PMC5984816</ArticleId><ArticleId IdType="pubmed">29859100</ArticleId></ArticleIdList></Reference><Reference><Citation>Murdock BJ, et al. Amyotrophic lateral sclerosis survival associates with neutrophils in a sex-specific manner. Neurol Neuroimmunol Neuroinflamm. 2021;8(2):e953. doi: 10.1212/NXI.0000000000000953.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000953</ArticleId><ArticleId IdType="pmc">PMC8057067</ArticleId><ArticleId IdType="pubmed">33531377</ArticleId></ArticleIdList></Reference><Reference><Citation>Vivier E, et al. Functions of natural killer cells. Nat Immunol. 2008;9(5):503&#x2013;510. doi: 10.1038/ni1582.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni1582</ArticleId><ArticleId IdType="pubmed">18425107</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies AJ, et al. Natural killer cells degenerate intact sensory afferents following nerve injury. Cell. 2019;176(4):716&#x2013;728. doi: 10.1016/j.cell.2018.12.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.12.022</ArticleId><ArticleId IdType="pmc">PMC6418410</ArticleId><ArticleId IdType="pubmed">30712871</ArticleId></ArticleIdList></Reference><Reference><Citation>Song S, et al. Major histocompatibility complex class I molecules protect motor neurons from astrocyte-induced toxicity in amyotrophic lateral sclerosis. Nat Med. 2016;22(4):397&#x2013;403. doi: 10.1038/nm.4052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4052</ArticleId><ArticleId IdType="pmc">PMC4823173</ArticleId><ArticleId IdType="pubmed">26928464</ArticleId></ArticleIdList></Reference><Reference><Citation>Gustafson MP, et al. Comprehensive immune profiling reveals substantial immune system alterations in a subset of patients with amyotrophic lateral sclerosis. PLoS One. 2017;12(7):e0182002. doi: 10.1371/journal.pone.0182002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0182002</ArticleId><ArticleId IdType="pmc">PMC5526569</ArticleId><ArticleId IdType="pubmed">28742871</ArticleId></ArticleIdList></Reference><Reference><Citation>Finkelstein A, et al. Abnormal changes in NKT cells, the IGF-1 axis, and liver pathology in an animal model of ALS. PLoS One. 2011;6(8):e22374. doi: 10.1371/journal.pone.0022374.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0022374</ArticleId><ArticleId IdType="pmc">PMC3149057</ArticleId><ArticleId IdType="pubmed">21829620</ArticleId></ArticleIdList></Reference><Reference><Citation>Garofalo S, et al. Natural killer cells modulate motor neuron-immune cell cross talk in models of amyotrophic lateral sclerosis. Nat Commun. 2020;11(1):1773. doi: 10.1038/s41467-020-15644-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-15644-8</ArticleId><ArticleId IdType="pmc">PMC7156729</ArticleId><ArticleId IdType="pubmed">32286313</ArticleId></ArticleIdList></Reference><Reference><Citation>Hewagama A, et al. Stronger inflammatory/cytotoxic T-cell response in women identified by microarray analysis. Genes Immun. 2009;10(5):509&#x2013;516. doi: 10.1038/gene.2009.12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gene.2009.12</ArticleId><ArticleId IdType="pmc">PMC2735332</ArticleId><ArticleId IdType="pubmed">19279650</ArticleId></ArticleIdList></Reference><Reference><Citation>vom Steeg LG, Klein SL. SeXX matters in infectious disease pathogenesis. PLoS Pathog. 2016;12(2):e1005374. doi: 10.1371/journal.ppat.1005374.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005374</ArticleId><ArticleId IdType="pmc">PMC4759457</ArticleId><ArticleId IdType="pubmed">26891052</ArticleId></ArticleIdList></Reference><Reference><Citation>Kodama L, et al. Microglial microRNAs mediate sex-specific responses to tau pathology. Nat Neurosci. 2020;23(2):167&#x2013;171. doi: 10.1038/s41593-019-0560-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0560-7</ArticleId><ArticleId IdType="pmc">PMC7394069</ArticleId><ArticleId IdType="pubmed">31873194</ArticleId></ArticleIdList></Reference><Reference><Citation>Manjaly ZR, et al. The sex ratio in amyotrophic lateral sclerosis: a population based study. Amyotroph Lateral Scler. 2010;11(5):439&#x2013;442. doi: 10.3109/17482961003610853.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482961003610853</ArticleId><ArticleId IdType="pmc">PMC6485484</ArticleId><ArticleId IdType="pubmed">20225930</ArticleId></ArticleIdList></Reference><Reference><Citation>Montaldo E, et al. Human NK cell receptors/markers: a tool to analyze NK cell development, subsets and function. Cytometry A. 2013;83(8):702&#x2013;713.</Citation><ArticleIdList><ArticleId IdType="pubmed">23650273</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueroa-Romero C, et al. Temporal evolution of the microbiome, immune system and epigenome with disease progression in ALS mice. Dis Model Mech. 2019;13(2):dmm041947.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6906635</ArticleId><ArticleId IdType="pubmed">31597644</ArticleId></ArticleIdList></Reference><Reference><Citation>McKinlay SM. The normal menopause transition: an overview. Maturitas. 1996;23(2):137&#x2013;145. doi: 10.1016/0378-5122(95)00985-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0378-5122(95)00985-X</ArticleId><ArticleId IdType="pubmed">8735352</ArticleId></ArticleIdList></Reference><Reference><Citation>Murdock BJ, et al. Increased ratio of circulating neutrophils to monocytes in amyotrophic lateral sclerosis. Neurol Neuroimmunol Neuroinflamm. 2016;3(4):e242. doi: 10.1212/NXI.0000000000000242.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000242</ArticleId><ArticleId IdType="pmc">PMC4897983</ArticleId><ArticleId IdType="pubmed">27308304</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers DR, et al. CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS. Proc Natl Acad Sci U S A. 2008;105(40):15558&#x2013;15563. doi: 10.1073/pnas.0807419105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0807419105</ArticleId><ArticleId IdType="pmc">PMC2547419</ArticleId><ArticleId IdType="pubmed">18809917</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin M, et al. Peripheral proinflammatory Th1/Th17 immune cell shift is linked to disease severity in amyotrophic lateral sclerosis. Sci Rep. 2020;10(1):5941. doi: 10.1038/s41598-020-62756-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-62756-8</ArticleId><ArticleId IdType="pmc">PMC7125229</ArticleId><ArticleId IdType="pubmed">32246039</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam L, et al. Epigenetic changes in T-cell and monocyte signatures and production of neurotoxic cytokines in ALS patients. FASEB J. 2016;30(10):3461&#x2013;3473. doi: 10.1096/fj.201600259RR.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201600259RR</ArticleId><ArticleId IdType="pmc">PMC5024692</ArticleId><ArticleId IdType="pubmed">27368295</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers DR, et al. Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis. Brain. 2011;134(Pt 5):1293&#x2013;1314.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3097891</ArticleId><ArticleId IdType="pubmed">21596768</ArticleId></ArticleIdList></Reference><Reference><Citation>Henkel JS, et al. Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival. EMBO Mol Med. 2013;5(1):64&#x2013;79. doi: 10.1002/emmm.201201544.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/emmm.201201544</ArticleId><ArticleId IdType="pmc">PMC3569654</ArticleId><ArticleId IdType="pubmed">23143995</ArticleId></ArticleIdList></Reference><Reference><Citation>Zondler L, et al. Peripheral monocytes are functionally altered and invade the CNS in ALS patients. Acta Neuropathol. 2016;132(3):391&#x2013;411. doi: 10.1007/s00401-016-1548-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1548-y</ArticleId><ArticleId IdType="pubmed">26910103</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang D, et al. The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system. FASEB J. 2006;20(7):896&#x2013;905. doi: 10.1096/fj.05-5465com.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.05-5465com</ArticleId><ArticleId IdType="pubmed">16675847</ArticleId></ArticleIdList></Reference><Reference><Citation>Moretta A, et al. Natural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis. Immunol Today. 2000;21(5):228&#x2013;234. doi: 10.1016/S0167-5699(00)01596-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0167-5699(00)01596-6</ArticleId><ArticleId IdType="pubmed">10782054</ArticleId></ArticleIdList></Reference><Reference><Citation>Potluri T, et al. Age-associated changes in the impact of sex steroids on influenza vaccine responses in males and females. NPJ Vaccines. 2019;4:29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6626024</ArticleId><ArticleId IdType="pubmed">31312529</ArticleId></ArticleIdList></Reference><Reference><Citation>Melgert BN, et al. Macrophages: regulators of sex differences in asthma? Am J Respir Cell Mol Biol. 2010;42(5):595&#x2013;603. doi: 10.1165/rcmb.2009-0016OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2009-0016OC</ArticleId><ArticleId IdType="pmc">PMC2874445</ArticleId><ArticleId IdType="pubmed">19574533</ArticleId></ArticleIdList></Reference><Reference><Citation>Vom Steeg LG, et al. Irradiated sporozoite vaccination induces sex-specific immune responses and protection against malaria in mice. Vaccine. 2019;37(32):4468&#x2013;4476. doi: 10.1016/j.vaccine.2019.06.075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2019.06.075</ArticleId><ArticleId IdType="pmc">PMC7862922</ArticleId><ArticleId IdType="pubmed">31262583</ArticleId></ArticleIdList></Reference><Reference><Citation>Yazdani S, et al. Peripheral immune biomarkers and neurodegenerative diseases: a prospective cohort study with 20&#x2009;years of follow-up. Ann Neurol. 2019;86(6):913&#x2013;926. doi: 10.1002/ana.25614.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25614</ArticleId><ArticleId IdType="pmc">PMC7611591</ArticleId><ArticleId IdType="pubmed">31604369</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardona AE, et al. Control of microglial neurotoxicity by the fractalkine receptor. Nat Neurosci. 2006;9(7):917&#x2013;924. doi: 10.1038/nn1715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1715</ArticleId><ArticleId IdType="pubmed">16732273</ArticleId></ArticleIdList></Reference><Reference><Citation>McCombe PA, Henderson RD. Effects of gender in amyotrophic lateral sclerosis. Gend Med. 2010;7(6):557&#x2013;570. doi: 10.1016/j.genm.2010.11.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genm.2010.11.010</ArticleId><ArticleId IdType="pubmed">21195356</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Azzawi F, Palacios S. Hormonal changes during menopause. Maturitas. 2009;63(2):135&#x2013;137. doi: 10.1016/j.maturitas.2009.03.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.maturitas.2009.03.009</ArticleId><ArticleId IdType="pubmed">19372016</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldman HA, et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab. 2002;87(2):589&#x2013;598. doi: 10.1210/jcem.87.2.8201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jcem.87.2.8201</ArticleId><ArticleId IdType="pubmed">11836290</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirshev SV, et al. Hormonal regulation of NK cell cytotoxic activity. Dokl Biol Sci. 2017;472(1):28&#x2013;30. doi: 10.1134/S0012496617010021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1134/S0012496617010021</ArticleId><ArticleId IdType="pubmed">28429258</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenz KM, et al. Microglia are essential to masculinization of brain and behavior. J Neurosci. 2013;33(7):2761&#x2013;2772. doi: 10.1523/JNEUROSCI.1268-12.2013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1268-12.2013</ArticleId><ArticleId IdType="pmc">PMC3727162</ArticleId><ArticleId IdType="pubmed">23407936</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenz KM, et al. Prostaglandin E(2) regulates AMPA receptor phosphorylation and promotes membrane insertion in preoptic area neurons and glia during sexual differentiation. PloS One. 2011;6(4):e18500. doi: 10.1371/journal.pone.0018500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0018500</ArticleId><ArticleId IdType="pmc">PMC3072395</ArticleId><ArticleId IdType="pubmed">21490976</ArticleId></ArticleIdList></Reference><Reference><Citation>Streit WJ, Xue QS. Human CNS immune senescence and neurodegeneration. Curr Opin Immunol. 2014;29:93&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">24908174</ArticleId></ArticleIdList></Reference><Reference><Citation>Almer G, et al. Increased levels of the pro-inflammatory prostaglandin PGE2 in CSF from ALS patients. Neurology. 2002;58(8):1277&#x2013;1279. doi: 10.1212/WNL.58.8.1277.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.58.8.1277</ArticleId><ArticleId IdType="pubmed">11971099</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang X, et al. The prostaglandin E2 EP2 receptor accelerates disease progression and inflammation in a model of amyotrophic lateral sclerosis. Ann Neurol. 2008;64(3):304&#x2013;314. doi: 10.1002/ana.21437.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21437</ArticleId><ArticleId IdType="pmc">PMC2766522</ArticleId><ArticleId IdType="pubmed">18825663</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalinski P. Regulation of immune responses by prostaglandin E2. J Immunol. 2012;188(1):21&#x2013;28. doi: 10.4049/jimmunol.1101029.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1101029</ArticleId><ArticleId IdType="pmc">PMC3249979</ArticleId><ArticleId IdType="pubmed">22187483</ArticleId></ArticleIdList></Reference><Reference><Citation>Murdock BJ, et al. Coevolution of TH1, TH2, and TH17 responses during repeated pulmonary exposure to Aspergillus fumigatus conidia. Infect Immun. 2011;79(1):125&#x2013;135. doi: 10.1128/IAI.00508-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/IAI.00508-10</ArticleId><ArticleId IdType="pmc">PMC3019910</ArticleId><ArticleId IdType="pubmed">21041495</ArticleId></ArticleIdList></Reference><Reference><Citation>Costantini C, et al. Neutrophil activation and survival are modulated by interaction with NK cells. Int Immunol. 2010;22(10):827&#x2013;838. doi: 10.1093/intimm/dxq434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/dxq434</ArticleId><ArticleId IdType="pubmed">20739460</ArticleId></ArticleIdList></Reference><Reference><Citation>Sporri R, et al. A novel role for neutrophils as critical activators of NK cells. J Immunol. 2008;181(10):7121&#x2013;7130. doi: 10.4049/jimmunol.181.10.7121.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.181.10.7121</ArticleId><ArticleId IdType="pubmed">18981133</ArticleId></ArticleIdList></Reference><Reference><Citation>Costantini C, Cassatella MA. The defensive alliance between neutrophils and NK cells as a novel arm of innate immunity. J Leukoc Biol. 2011;89(2):221&#x2013;233. doi: 10.1189/jlb.0510250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.0510250</ArticleId><ArticleId IdType="pubmed">20682626</ArticleId></ArticleIdList></Reference><Reference><Citation>Nekrasova, Shirshev SV. Female sex steroid hormones in regulation of neutrophil enzymatic activity. Dokl Biochem Biophys. 2013;453:312&#x2013;315. doi: 10.1134/S1607672913060100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1134/S1607672913060100</ArticleId><ArticleId IdType="pubmed">24385104</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16(10):626&#x2013;638. doi: 10.1038/nri.2016.90.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2016.90</ArticleId><ArticleId IdType="pubmed">27546235</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon AK, et al. Evolution of the immune system in humans from infancy to old age. Proc Biol Sci. 2015;282(1821):20143085.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4707740</ArticleId><ArticleId IdType="pubmed">26702035</ArticleId></ArticleIdList></Reference><Reference><Citation>Hooten KG, et al. Protective and toxic neuroinflammation in amyotrophic lateral sclerosis. Neurotherapeutics. 2015;12(2):364&#x2013;375. doi: 10.1007/s13311-014-0329-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-014-0329-3</ArticleId><ArticleId IdType="pmc">PMC4404435</ArticleId><ArticleId IdType="pubmed">25567201</ArticleId></ArticleIdList></Reference><Reference><Citation>Musicco M. Gender differences in the occurrence of Alzheimer&#x2019;s disease. Funct Neurol. 2009;24(2):89&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">19775536</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawas C, et al. Age-specific incidence rates of Alzheimer&#x2019;s disease: the Baltimore Longitudinal Study of Aging. Neurology. 2000;54(11):2072&#x2013;2077. doi: 10.1212/WNL.54.11.2072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.54.11.2072</ArticleId><ArticleId IdType="pubmed">10851365</ArticleId></ArticleIdList></Reference><Reference><Citation>Voskuhl RR. The effect of sex on multiple sclerosis risk and disease progression. Mult Scler. 2020;26(5):554&#x2013;560. doi: 10.1177/1352458519892491.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1352458519892491</ArticleId><ArticleId IdType="pmc">PMC7160019</ArticleId><ArticleId IdType="pubmed">31965884</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein SL, Morgan R. The impact of sex and gender on immunotherapy outcomes. Biol Sex Differ. 2020;11(1):24. doi: 10.1186/s13293-020-00301-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13293-020-00301-y</ArticleId><ArticleId IdType="pmc">PMC7197158</ArticleId><ArticleId IdType="pubmed">32366281</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Q, et al. Correlation between patients&#x2019; age and cancer immunotherapy efficacy. Oncoimmunology. 2019;8(4):e1568810.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6422380</ArticleId><ArticleId IdType="pubmed">30906662</ArticleId></ArticleIdList></Reference><Reference><Citation>Conforti F, et al. Cancer immunotherapy efficacy and patients&#x2019; sex: a systematic review and meta-analysis. Lancet Oncol. 2018;19(6):737&#x2013;746. doi: 10.1016/S1470-2045(18)30261-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1470-2045(18)30261-4</ArticleId><ArticleId IdType="pubmed">29778737</ArticleId></ArticleIdList></Reference><Reference><Citation>Carson MJ, et al. Mature microglia resemble immature antigen-presenting cells. Glia. 1998;22(1):72&#x2013;85. doi: 10.1002/(SICI)1098-1136(199801)22:1&lt;72::AID-GLIA7&gt;3.0.CO;2-A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1098-1136(199801)22:1&lt;72::AID-GLIA7&gt;3.0.CO;2-A</ArticleId><ArticleId IdType="pubmed">9436789</ArticleId></ArticleIdList></Reference><Reference><Citation>Razali NM, Wah YB. Power comparisons of Shapiro-Wilk, Kolmogorov-Smirnov, Lilliefors and Anderson-Darling tests. Journal of Statistical Modeling and Analytics. 2011;2(1):21&#x2013;33.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>